 | | PRD_002118 | | Name: | N-[(4Z)-6-oxo-6-phenylhex-4-enoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-threoninamide | | Formula: | C39 H53 N6 O10 P | | Definition date: | 2014-12-03 | | Last modified: | 2014-12-03 |
|
 | | PRD_001254 | | Name: | PL-2 | | Formula: | C29 H45 N6 O9 P | | Definition date: | 2014-11-19 | | Last modified: | 2014-11-19 |
|
 | | PRD_002115 | | Name: | (3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-24-{(2R)-1-[4-(2-methoxyethyl)piperazin-1-yl]propan-2-yl}-1,4,7,10,12,15,19,25,27,28-decamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | | Formula: | C69 H125 N13 O13 | | Definition date: | 2014-11-12 | | Last modified: | 2014-11-12 |
|
 | | PRD_001080 | | Name: | Peptide inhibitor MPT-DPP-ARG-G-LEU-NH2 | | Formula: | C20 H40 N9 O5 S | | Definition date: | 2014-10-15 | | Last modified: | 2014-10-15 |
|
 | | PRD_001191 | | Name: | iCAL36(BRB-K-1) peptide | | Formula: | C58 H86 Br N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001192 | | Name: | iCAL36(TFA-K-1) peptide | | Formula: | C53 H82 F3 N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001193 | | Name: | iCAL36(FLB-K-1) peptide | | Formula: | C58 H86 F N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001194 | | Name: | iCAL36(Ac-K-5) peptide | | Formula: | C48 H86 N15 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001195 | | Name: | iCAL36(Ac-K-4) peptide | | Formula: | C54 H89 N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001196 | | Name: | iCAL36(Ac-K-3) peptide | | Formula: | C55 H89 N16 O15 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001197 | | Name: | iCAL36(Ac-K-1) peptide | | Formula: | C53 H85 N16 O16 | | Definition date: | 2014-10-01 | | Last modified: | 2014-10-01 |
|
 | | PRD_001222 | | Name: | bicyclic peptide UK601 (bicyclic 1) | | Formula: | C59 H101 N24 O17 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001223 | | Name: | bicyclic peptide UK602 (bicyclic 1) | | Formula: | C56 H96 N23 O16 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001224 | | Name: | bicyclic peptide UK603 (bicyclic 1) | | Formula: | C59 H101 N24 O17 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001225 | | Name: | bicyclic peptide UK604 (bicyclic 2) | | Formula: | C56 H96 N23 O16 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001226 | | Name: | bicyclic peptide UK607 (bicyclic) | | Formula: | C64 H110 N25 O18 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001227 | | Name: | bicyclic peptide UK603 (bicyclic 2) | | Formula: | C59 H101 N24 O17 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001232 | | Name: | Alpha-conotoxin ImI mutant | | Formula: | C54 H84 N20 O15 S4 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001251 | | Name: | ACE-PHE-ALA-THR-ALA-0QE | | Formula: | C22 H31 Cl N4 O6 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_001252 | | Name: | ACE-ILE-ALA-THR-ALA-0QE | | Formula: | C19 H33 Cl N4 O6 | | Definition date: | 2014-09-24 | | Last modified: | 2014-09-24 |
|
 | | PRD_002089 | | Name: | (1R,2S,19S,22R,34S,37R,40S,52S)-2-{[(2R,3S,4R,5R,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-22-amino-5,15-dichloro-64-({(2R,3R,4S,5S,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(8-methylnonanoyl)amino]tetrahydro-2H-pyran-2-yl}oxy)-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-{[(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-7,13,28-trioxa-20,36,39,53,55,58-hexaazaundecacyclo[38.14.2.2~3,6~.2~14,17~.2~19,34~.1~8,12~.1~23,27~.1~29,33~.1~41,45~.0~10,37~.0~46,51~]hexahexaconta-3,5,8(64),9,11,14,16,23(61),24,26,29(60),30,32,41(57),42,44,46,48,50,62,65-henicosaene-52-carboxylic acid (non-preferred name) | | Formula: | C88 H97 Cl2 N9 O33 | | Definition date: | 2014-09-10 | | Last modified: | 2014-09-10 |
|
 | | PRD_001158 | | Name: | Teicoplanin pseudoaglycone | | Formula: | C78 H79 Cl2 N9 O32 | | Definition date: | 2014-09-03 | | Last modified: | 2014-09-03 |
|
 | | PRD_001169 | | Name: | Teicoplanin pseudoaglycone | | Formula: | C88 H97 Cl2 N9 O33 | | Definition date: | 2014-09-03 | | Last modified: | 2014-09-03 |
|
 | | PRD_002101 | | Name: | N-[(6R,9S,10R,13S,15aR,22S,24aR)-22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-18-(morpholin-4-ylmethyl)-5,8,12,15,21,24-hexaoxo-13-phenyl-1,2,3,5,6,7,8,9,10,13,14,15,15a,16,19,21,22,23,24,24a-icosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxypyridine-2-carboxamide | | Formula: | C50 H63 N9 O10 | | Definition date: | 2014-07-30 | | Last modified: | 2014-07-30 |
|
 | | PRD_001171 | | Name: | Serine protease inhibitor BEZ-NLE-LYS-ARG-M9P | | Formula: | C32 H57 F3 N11 O5 | | Definition date: | 2014-07-08 | | Last modified: | 2014-07-08 |
|
